Cargando…

In Silico Methods in Antibody Design

Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Nussinov, Ruth, Wu, Wen-Jin, Ma, Buyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640671/
https://www.ncbi.nlm.nih.gov/pubmed/31544874
http://dx.doi.org/10.3390/antib7030022
_version_ 1783436619344248832
author Zhao, Jun
Nussinov, Ruth
Wu, Wen-Jin
Ma, Buyong
author_facet Zhao, Jun
Nussinov, Ruth
Wu, Wen-Jin
Ma, Buyong
author_sort Zhao, Jun
collection PubMed
description Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen structures, engineering the function of antibodies and design antibody-antigen complexes with improved properties. This review summarizes recent progress in the field of in silico design of antibodies, including antibody structure modeling, antibody-antigen complex prediction, antibody stability evaluation, and allosteric effects in antibodies and functions. We listed the cases in which these methods have helped experimental studies to improve the affinities and physicochemical properties of antibodies. We emphasized how the molecular dynamics unveiled the allosteric effects during antibody-antigen recognition and antibody-effector recognition.
format Online
Article
Text
id pubmed-6640671
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66406712019-09-05 In Silico Methods in Antibody Design Zhao, Jun Nussinov, Ruth Wu, Wen-Jin Ma, Buyong Antibodies (Basel) Review Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen structures, engineering the function of antibodies and design antibody-antigen complexes with improved properties. This review summarizes recent progress in the field of in silico design of antibodies, including antibody structure modeling, antibody-antigen complex prediction, antibody stability evaluation, and allosteric effects in antibodies and functions. We listed the cases in which these methods have helped experimental studies to improve the affinities and physicochemical properties of antibodies. We emphasized how the molecular dynamics unveiled the allosteric effects during antibody-antigen recognition and antibody-effector recognition. MDPI 2018-06-29 /pmc/articles/PMC6640671/ /pubmed/31544874 http://dx.doi.org/10.3390/antib7030022 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhao, Jun
Nussinov, Ruth
Wu, Wen-Jin
Ma, Buyong
In Silico Methods in Antibody Design
title In Silico Methods in Antibody Design
title_full In Silico Methods in Antibody Design
title_fullStr In Silico Methods in Antibody Design
title_full_unstemmed In Silico Methods in Antibody Design
title_short In Silico Methods in Antibody Design
title_sort in silico methods in antibody design
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640671/
https://www.ncbi.nlm.nih.gov/pubmed/31544874
http://dx.doi.org/10.3390/antib7030022
work_keys_str_mv AT zhaojun insilicomethodsinantibodydesign
AT nussinovruth insilicomethodsinantibodydesign
AT wuwenjin insilicomethodsinantibodydesign
AT mabuyong insilicomethodsinantibodydesign